Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Gastritis-II: Pathophysiology

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...

Hypersensitivity Reactions: Immune-Complex Reactions

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...

Autoimmune Disorders

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...

Drug Toxicity: Allergic Reactions

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...

Skin Diseases and Disorders

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Trichophyton mentagrophytes ITS genotype VIII/Trichophyton indotineae in Germany-revisit after 5 years].

Dermatologie (Heidelberg, Germany)·2025

Same author

Type 2 T-Cell Responses against Distinct Epitopes of the Desmoglein 3 Ectodomain in Pemphigus Vulgaris.

The Journal of investigative dermatology·2023

Same author

Mast cell deficiency prevents BCR::ABL1 induced splenomegaly and cytokine elevation in a CML mouse model.

Leukemia·2023

Same author

Survival and prognostic factors in bullous pemphigoid: A retrospective cohort study.

Indian journal of dermatology, venereology and leprology·2022

Same author

Anti-FcαRI Monoclonal Antibodies Resolve IgA Autoantibody-Mediated Disease.

Frontiers in immunology·2022

Same author

Challenges and pitfalls between lichen planus pemphigoides and bullous lichen planus.

The Australasian journal of dermatology·2022

Search research articles

Related Experiment Video

Updated: Jul 10, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

IgG4 autoantibodies induce dermal-epidermal separation.

Sidonia Mihai¹, Mircea T Chiriac, Josep E Herrero-González

¹Department of Dermatology, University of Lübeck, Lübeck, Germany.

Journal of Cellular and Molecular Medicine

|November 6, 2007

Summary

Bullous pemphigoid IgG4 autoantibodies activate immune cells and cause skin damage, challenging previous assumptions about their role in autoimmune blistering diseases.

More Related Videos

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis

Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis

Published on: September 26, 2012

Related Experiment Videos

Last Updated: Jul 10, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis

Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis

Published on: September 26, 2012

Area of Science:

Immunology
Dermatology
Autoimmune Diseases

Background:

Bullous pemphigoid (BP) is a sub-epidermal autoimmune blistering disease.
Autoantibodies targeting the dermal-epidermal junction (DEJ) are central to BP pathogenesis.
The role of IgG4 autoantibodies in mediating tissue damage in BP is not well understood.

Purpose of the Study:

To investigate the blister-inducing potential of IgG1 and IgG4 autoantibodies from bullous pemphigoid patients.
To determine if IgG4 autoantibodies can activate leucocytes and cause dermal-epidermal separation.

Main Methods:

Isolation of IgG1 and IgG4 autoantibodies from bullous pemphigoid patient serum.
Utilizing a cryosection assay with human skin and leucocytes.
Assessing complement fixation and leucocyte activation by isolated autoantibodies.

Main Results:

Complement-fixing IgG1 autoantibodies induced sub-epidermal splits, as expected.
Purified IgG4 autoantibodies did not fix complement but activated leucocytes.
Both IgG1 and IgG4 autoantibodies induced dermal-epidermal separation, with IgG4 showing lower potency.

Conclusions:

Bullous pemphigoid IgG4 autoantibodies can activate leucocytes, revealing a previously unrecognized function.
This study provides the first clear evidence that bullous pemphigoid IgG4 autoantibodies can induce leucocyte-dependent tissue damage.
The findings suggest a more significant role for IgG4 in autoimmune blistering diseases than previously thought.